The growth curve of xenografts showed that after ADAM17 knockdown, the transplanted tumor cells were more sensitive to TMZ, and the difference was statistically significant on day 19 after TMZ administration (Figure 5B). The gene discussed is ADAM17; the disease is neoplasm.